Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

Administration Announces Update on Overdose Prevent Strategy

Posted 2/4/2024

On Feb. 1, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule that updates regulations for Opioid Treatment Programs (OTP) and the standards for treatment of opioid use disorder (OUD). The rule makes some COVID-19-related flexibilities permanent, including take-home doses of methadone, the ability of an OTP to prescribe medication for OUD via telehealth without an initial in-person physical evaluation, and the removal of certain requirements for admission to an OTP to better align with evidence-based practice. The rule also promotes patient-centered models of care that are aligned with management approaches for other chronic conditions. Additional details are available on the SAMHSA website.

Back to all news

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more

All Sponsors